Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Berneman

Showing results (41-50 of 219) with videos related to

Pageof 22
Sort By:
Clinical & Developmental Immunology|March 5, 2008
Regulatory T cells and human diseaseNathalie Cools, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
Current HIV Research|April 1, 2010
Role of dendritic cells in HIV-immunotherapyEllen Van Gulck, Viggo F Van Tendeloo, Zwi N Berneman, et al.
Cytotherapy|June 13, 2012
Dendritic cell vaccination in acute myeloid leukemiaSébastien Anguille, Yannick Willemen, Eva Lion, et al.
Intervirology|January 1, 1997
Identification of envelope glycoproteins H and B homologues of human herpesvirus 7P Secchiero, Z N Berneman, D Sun, et al.
Journal of Leukocyte Biology|August 23, 2007
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cellsNathalie Cools, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
Journal of Virological Methods|May 1, 1994
Detection of human herpesvirus-6 in paraffin-embedded tissue of cervical cancer by polymerase chain reactionH Wang, M Chen, Z N Berneman, et al.
The Oncologist|March 18, 2009
Immunotherapy of acute myeloid leukemia: current approachesEvelien L J M Smits, Zwi N Berneman, Viggo F I Van Tendeloo
Cancers|February 5, 2020
Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?Yannick Willemen, Maarten Versteven, Marc Peeters, et al.
Human Vaccines|March 23, 2011
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answersSébastien Anguille, Eva Lion, Evelien Smits, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 2, 2013
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?A H Nuyts, W P Lee, R Bashir-Dar, et al.
Pageof 22

Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
Clinical & Developmental Immunology|March 5, 2008
Regulatory T cells and human diseaseNathalie Cools, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
Current HIV Research|April 1, 2010
Role of dendritic cells in HIV-immunotherapyEllen Van Gulck, Viggo F Van Tendeloo, Zwi N Berneman, et al.
Cytotherapy|June 13, 2012
Dendritic cell vaccination in acute myeloid leukemiaSébastien Anguille, Yannick Willemen, Eva Lion, et al.
Intervirology|January 1, 1997
Identification of envelope glycoproteins H and B homologues of human herpesvirus 7P Secchiero, Z N Berneman, D Sun, et al.
Journal of Leukocyte Biology|August 23, 2007
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cellsNathalie Cools, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
Journal of Virological Methods|May 1, 1994
Detection of human herpesvirus-6 in paraffin-embedded tissue of cervical cancer by polymerase chain reactionH Wang, M Chen, Z N Berneman, et al.
The Oncologist|March 18, 2009
Immunotherapy of acute myeloid leukemia: current approachesEvelien L J M Smits, Zwi N Berneman, Viggo F I Van Tendeloo
Cancers|February 5, 2020
Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?Yannick Willemen, Maarten Versteven, Marc Peeters, et al.
Human Vaccines|March 23, 2011
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answersSébastien Anguille, Eva Lion, Evelien Smits, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 2, 2013
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?A H Nuyts, W P Lee, R Bashir-Dar, et al.
Pageof 22